Advertisement

Sleep and Vigilance

, Volume 1, Issue 1, pp 47–48 | Cite as

The SAVE Trial: Has the Importance of CPAP for Preventing Cardiovascular Events been Discounted?

  • Ahmed S. BahammamEmail author
  • Seithikurippu R. Pandi-PerumalEmail author
  • David Warren Spence
  • Adam Moscovitch
  • David L. Streiner
Correspondence

A paper by McEvoy et al. recently appeared in the New England Journal of Medicine concerning the role of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea (OSA) [1]. The primary composite end point of the study was death from cardiovascular causes, myocardial infarction, stroke, or hospitalization for unstable angina, heart failure, or transient ischemic attack. The results of this paper, apparently showing that CPAP had no protective effect against various forms of cardiovascular disease (CVD), came as a surprise to us in light of the accumulated evidence linking OSA with CVD. The currently available data from randomized controlled trials (RCTs) have shown that CPAP has beneficial effects on factors associated with CVD such as blood pressure, increased sympathetic activity, endothelial function, and insulin sensitivity [2, 3]. In addition, several observational studies have shown that CPAP use reduces the...

Keywords

Obstructive Sleep Apnea Continuous Positive Airway Pressure Obstructive Sleep Apnea Patient Severe Obstructive Sleep Apnea Oxygen Desaturation Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919–31.CrossRefPubMedGoogle Scholar
  2. 2.
    Bauters F, Rietzschel ER, Hertegonne KB, Chirinos JA. The link between obstructive sleep apnea and cardiovascular disease. Curr Atheroscler Rep. 2016;18(1):1.CrossRefPubMedGoogle Scholar
  3. 3.
    Khayat R, Pleister A. Consequences of obstructive sleep apnea: cardiovascular risk of obstructive sleep apnea and whether continuous positive airway pressure reduces that risk. Sleep Med Clin. 2016;11(3):273–86.CrossRefPubMedGoogle Scholar
  4. 4.
    Mokhlesi B, Ayas NT. Cardiovascular events in obstructive sleep Apnea—Can CPAP therapy SAVE lives? N Engl J Med. 2016;375(10):994–6.CrossRefPubMedGoogle Scholar
  5. 5.
    BaHammam AS, Sharif M, Gacuan DE, George S. Evaluation of the accuracy of manual and automatic scoring of a single airflow channel in patients with a high probability of obstructive sleep apnea. Med Sci Monit. 2011;17(2):MT13–9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Weinreich G, Armitstead J, Topfer V, Wang YM, Wang Y, Teschler H. Validation of ApneaLink as screening device for Cheyne-Stokes respiration. Sleep. 2009;32(4):553–7.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable monitoring task force of the American academy of sleep medicine. J Clin Sleep Med. 2007;3(7):737–47.PubMedGoogle Scholar
  8. 8.
    Antic NA, Heeley E, Anderson CS, Luo Y, Wang J, Neal B, et al. The sleep apnea cardiovascular endpoints (SAVE) Trial: rationale, ethics, design, and progress. Sleep. 2015;38(8):1247–57.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gantner D, Ge JY, Li LH, Antic N, Windler S, Wong K, et al. Diagnostic accuracy of a questionnaire and simple home monitoring device in detecting obstructive sleep apnoea in a Chinese population at high cardiovascular risk. Respirology. 2010;15(6):952–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Chen H, Lowe AA, Bai Y, Hamilton P, Fleetham JA, Almeida FR. Evaluation of a portable recording device (ApneaLink) for case selection of obstructive sleep apnea. Sleep Breath. 2009;13(3):213–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Clark AL, Crabbe S, Aziz A, Reddy P, Greenstone M. Use of a screening tool for detection of sleep-disordered breathing. J Laryngol Otol. 2009;123(7):746–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Ong KC, Clerk AA. Comparison of the severity of sleep-disordered breathing in Asian and Caucasian patients seen at a sleep disorders center. Respir Med. 1998;92(6):843–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2017

Authors and Affiliations

  1. 1.Department of Medicine, College of Medicine, The University Sleep Disorders CenterKing Saud UniversityRiyadhSaudi Arabia
  2. 2.Somnogen Canada Inc.TorontoCanada
  3. 3.TorontoCanada
  4. 4.Sleep and Fatigue InstituteThe University of CalgaryCalgaryCanada
  5. 5.Department of Psychiatry and Behavioral NeurosciencesMcMaster UniversityHamiltonCanada
  6. 6.Department of PsychiatryUniversity of TorontoTorontoCanada

Personalised recommendations